$13.15
-0.49-3.63%
Last update: Nov 10, 7:25 PM
Vir Biotechnology Inc
VIRNASDAQ
Vir Biotechnology rose 154.1% from $5.37 to a 1-year high of $13.65, ahead of the S&P 500's +10.0%. Its worst day was May 7 (−9.9%), and its low came Nov 10 at $5.37.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Vir Biotechnology shares rose 15.7%, while the S&P 500 rose 1.2%.
+15.7% · S&P 500 +1.2%
EPS of $-0.31 beat the $-0.47 estimate on $64.1M revenue (est. $19.4M).
+27.7%, the year's best day, on 38M shares, the year's heaviest volume · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.85 missed the $0.38 estimate on $-29,000.00 revenue (est. $122.5M).
−9.9%, the year's worst day · S&P 500 −0.3%
EPS of $0.47 missed the $0.88 estimate on $238.9M revenue (est. $229.7M).
−3.8% · S&P 500 −0.2%
EPS of $-0.57 beat the $-0.76 estimate on $-188,000.00 revenue (est. $1.2M).
−6.4% · S&P 500 −4.4%
Where it ended: a 1-year high close of $13.64 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 22, 2027 (EPS est. $-0.35, revenue est. $38.4M).
Nothing in the past 12 months.
All VIR dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VIR and SPY from Benzinga historical bars. Not investment advice.
